| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/26/2004 | WO2003093818A3 Method for pre-treating stool samples |
| 02/26/2004 | WO2003089589A3 Matrix analysis of gene expression in cells (magec) |
| 02/26/2004 | WO2003088811A3 Gelsolin as a prognostic marker of artherosclerotic diseases |
| 02/26/2004 | WO2003087841A3 An ephrin-b receptor protein involved in carcinoma |
| 02/26/2004 | WO2003087775A3 Monitoring blood substances using self-sampled tears |
| 02/26/2004 | WO2003087345A3 Stimulation of nerve cell regeneration |
| 02/26/2004 | WO2003087132A3 Compositions and methods for evaluating and designing nuclear receptor ligands that modulate co-regulator affinity |
| 02/26/2004 | WO2003086199A3 A sample surface component for an instrument that measures viscosity and viscoelasticity |
| 02/26/2004 | WO2003084384A3 Diagnosis of flavivirus infection |
| 02/26/2004 | WO2003083489A9 System for performing blood coagulation assays and measuring blood clotting times |
| 02/26/2004 | WO2003083435A3 Single primer isothermal nucleic acid amplification-enhanced analyte detection and quantification |
| 02/26/2004 | WO2003079017A3 Device and method for determining specific particles in a liquid sample |
| 02/26/2004 | WO2003071270A3 Screening method |
| 02/26/2004 | WO2003070894A3 A non-invasive diagnostic test utilizing histone modification markers |
| 02/26/2004 | WO2003068979A9 System and methods for discriminating an agent |
| 02/26/2004 | WO2003068908A3 Cardiotoxin molecular toxicology modeling |
| 02/26/2004 | WO2003066906A3 Diagnostic microarray and method of use thereof |
| 02/26/2004 | WO2003066813A3 MINRs AS MODIFIERS OF INSULIN RECEPTOR SIGNALING AND METHODS OF USE |
| 02/26/2004 | WO2003064999A3 Methods for identifying modulators of receptor tyrosine kinases |
| 02/26/2004 | WO2003062401A3 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 02/26/2004 | WO2003061583A3 Digenic mutations associated with severe insulin resistance and type 2 diabetes and their use in the diagnosis and treatment of diabetes |
| 02/26/2004 | WO2003060056A3 Assembly for cell-based assays |
| 02/26/2004 | WO2003058193A3 Microarrays for cell phenotyping and manipulation |
| 02/26/2004 | WO2003057914A3 METHOD FOR DETECTING HUMAN PAPILLOMAVIRUS mRNA |
| 02/26/2004 | WO2003057845A3 Automated systems and methods for analysis of protein post-translational modification |
| 02/26/2004 | WO2003057829A3 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 02/26/2004 | WO2003057014A9 Biomarkers for detecting ovarian cancer |
| 02/26/2004 | WO2003056299A3 Labeling reagent and methods of use |
| 02/26/2004 | WO2003052412A3 Diagnosis of inflammatory bowel disease |
| 02/26/2004 | WO2003048783A3 Monocyte adhesion |
| 02/26/2004 | WO2003048333A3 Endorepellin compositions and methods for inhibiting angiogenesis |
| 02/26/2004 | WO2003047420A3 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 02/26/2004 | WO2003046568A3 Protein biopolymer markers indicative of a disease state |
| 02/26/2004 | WO2003046139A3 CRBs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHOD OF USE |
| 02/26/2004 | WO2003045321A3 MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE |
| 02/26/2004 | WO2003044533A3 Capture and detection phase of a target biological material for elisa tests |
| 02/26/2004 | WO2003043403A3 Methods and apparatus for blood typing with optical bio-discs |
| 02/26/2004 | WO2003042694A3 Characterization of molecules |
| 02/26/2004 | WO2003039476A3 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874 |
| 02/26/2004 | WO2003035840A3 69583 and 85924, novel human protein kinase family members and uses therefor |
| 02/26/2004 | WO2003035837A3 Novel compositions and methods for cancer |
| 02/26/2004 | WO2003033669A3 Methods for screening and identifying host pathogen defense genes |
| 02/26/2004 | WO2003031987A3 In vitro model for priocidal activity |
| 02/26/2004 | WO2003030719A3 Methods and kits for use in selecting approaches to treating cancer |
| 02/26/2004 | WO2003029813A3 Test strips for the detection of prion proteins |
| 02/26/2004 | WO2003028543A3 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease |
| 02/26/2004 | WO2003027682A3 Controlling isotope effects during fractionation of analytes |
| 02/26/2004 | WO2003025566A3 A method and kit for the measurement of the activation of basophils induced by allergen to determine hypersensitivity |
| 02/26/2004 | WO2003023406A9 Diagnostic method for transmissible spongiform encephalopathies |
| 02/26/2004 | WO2003020892A3 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY |
| 02/26/2004 | WO2003019157A8 High throughput mechanical rapid serial property testing of materials libraries |
| 02/26/2004 | WO2003012137A3 Methods for detecting parkinson's disease |
| 02/26/2004 | WO2003008449A8 Ntb-a, a surface molecule involved in natural killer cells activity |
| 02/26/2004 | WO2003004611A3 Human olfactory nucleotide-gated ion channels |
| 02/26/2004 | WO2002103050A3 Virus detection method, primers therefor and screening kit |
| 02/26/2004 | WO2002103002A3 Gene associated with leishmania parasite virulence |
| 02/26/2004 | WO2002102973A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 02/26/2004 | WO2002101089A3 Method for specific, fast detection of threadlike bacteria |
| 02/26/2004 | WO2002099047A3 PROMLs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 02/26/2004 | WO2002089737A8 Separation of platelets from whole blood for use as a healant |
| 02/26/2004 | WO2002085290A3 Edg : modulators of lymphocyte activation and migration |
| 02/26/2004 | WO2002083937A3 Methods using o6-alkylguanine-dna alkyltransferases |
| 02/26/2004 | WO2002083917A8 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 02/26/2004 | WO2002074921A3 Methods for isolating proteins expressed by dendritic cells |
| 02/26/2004 | WO2002074793A3 Novel peptides for the diagnosis of schizophrenia |
| 02/26/2004 | WO2002072636A8 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 02/26/2004 | WO2002066672A3 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 02/26/2004 | WO2002061134A3 Reagents and methods for identifying and modulating expression of tumor senescence genes |
| 02/26/2004 | WO2002056236A3 Classification of polypeptides by ligand geometry and related methods |
| 02/26/2004 | WO2002051237A3 Helicobacter proteins, nucleic acids and uses thereof |
| 02/26/2004 | WO2002046770A3 Isotope-coded ionization-enhancing reagents (icier) for high-throughput protein identification and quantitation using matrix-assisted laser desorption ionization mass spectrometry |
| 02/26/2004 | WO2002046451A3 Methods for the identification of inhibitors of cysteine syhthase in plants |
| 02/26/2004 | WO2002046418A3 Lipid-associated molecules |
| 02/26/2004 | WO2002046382A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | WO2002040985A3 Liquid and solid tissue mimicking material for ultrasound phantoms and method of making the same |
| 02/26/2004 | WO2002039122A3 Methods for the identification and the treatment of cardiovascular disease |
| 02/26/2004 | WO2002038796A3 Methods for determining protease cleavage site motifs |
| 02/26/2004 | WO2002029417A3 Dynamic visualization of expressed gene networks in living cells |
| 02/26/2004 | WO2002025282A8 Method for adhesion of polymers to metal-coated substrates |
| 02/26/2004 | WO2002016643A3 Dna pooling methods for quantitative traits using unrelated populations or sib pairs |
| 02/26/2004 | WO2002009576A3 Avian pneumovirus diagnostic system |
| 02/26/2004 | WO2001080715A3 Methods for identifying compounds useful for preventing acute clinical vascular events in a subject |
| 02/26/2004 | WO2001057175A3 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 02/26/2004 | WO2000045145A3 Method and device for measuring insulating fluids |
| 02/26/2004 | US20040040049 Reduction in the formation of the complex in the presence of the candidate agent as compared with in the absence of candidate agent indicates the candidate agent inhibits the binding of LBP-2 to the LBP-2 binding molecule |
| 02/26/2004 | US20040039719 Computerized identification of normal and abnormal diurnal cortisol secretion patterns and levels of testosterone from human saliva samples |
| 02/26/2004 | US20040039554 Iterative analysis of non-responding population in the design of pharmacogenetic studies |
| 02/26/2004 | US20040039553 Diagnosis method of inflammatory, fibrotic or cancerous disease using biochemical markers |
| 02/26/2004 | US20040039532 Feature quality in array fabrication |
| 02/26/2004 | US20040039530 Pharmacokinetic tool and method for predicting metabolism of a compound in a mammal |
| 02/26/2004 | US20040039514 Method and apparatus for controlling a gas-emitting process and related devices |
| 02/26/2004 | US20040039467 Systems & methods for realtime determination of asphalt content |
| 02/26/2004 | US20040039303 Blood testing apparatus |
| 02/26/2004 | US20040039281 Method for investigating the fate of a test compound or the stateof a biological system by means of nmr of hyperpolarised nmr active nuclei |
| 02/26/2004 | US20040039201 Functionalized compositions for improved immobilization |
| 02/26/2004 | US20040039185 Novel family member of inhibitor of apoptosis proteins |
| 02/26/2004 | US20040039184 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 02/26/2004 | US20040039178 Metal chelate-labelled peptides |
| 02/26/2004 | US20040039166 Newly identified polypeptides and polynucleotides encoding such polypeptides referred to as inhibitor of apoptosis proteins (IAPL-3); use in diagnosis and in identifying compounds that may be agonists, antagonists |
| 02/26/2004 | US20040039164 Invention relates to identification and isolation of novel DNA and to recombinant production of novel polypeptides |